Patients from 22+ countriesPlan your visit โ†’
lutetium-therapy
Patient Journey ยท Phase 4

After treatment ends.

Completing your final cycle is a milestone โ€” but Lutetium therapy is a long-acting treatment, and the months and years after are where its full benefit shows. Here's what follow-up looks like, what to watch for, and how to think about the road ahead.

Medically reviewedUpdated 16 May 2026
Older couple walking together through a garden at sunset, silhouetted from behind

The first 3 months after your last cycle

  • Radiation safety precautions ease and disappear by day 14 after your last cycle
  • Blood counts continue to recover; energy returns over weeks
  • Mild fatigue can linger 4โ€“8 weeks; usually resolves by 3 months
  • Side effects from the treatment phase fade

The first follow-up scan

Usually scheduled 3 months after your last cycle. This is important because Lutetium therapy has a delayed effect โ€” tumors continue dying for weeks after treatment ends. Scans done too early can miss this ongoing response.

  • For prostate cancer: PSMA PET, CT, sometimes bone scan
  • For NETs: Ga-68 DOTATATE PET, CT/MRI

Long-term monitoring

  • Every 3 months for the first 1โ€“2 years
  • Every 4โ€“6 months thereafter if stable
  • Tumor markers more frequently (every 1โ€“3 months)

What patterns to expect

Complete or near-complete response (a minority of patients)

Tumor markers drop to normal or near-normal. Scans show no active disease. Quality of life often improves dramatically. Monitoring continues but pressure eases.

Partial response (most patients who benefit)

Tumor markers drop significantly. Scans show shrinkage of tumors or fewer active sites. Disease is stable. Many patients live months to years in this state.

Stable disease

Markers and scans don't worsen. Tumors don't grow. This is also a meaningful outcome โ€” particularly for slow-growing NETs.

Progression

Markers rise; scans show new lesions or growth. This is the hardest outcome and triggers a conversation about next steps โ€” additional Lutetium cycles in some cases, other systemic therapies, or trials.

Frequently asked questions

Can I have Lutetium therapy again later?

Yes, re-treatment is possible in select cases. Patients who had good initial response and progressed years later may be candidates for an additional 2โ€“4 cycles. Considerations include cumulative kidney and bone marrow exposure.

What's the longest someone has stayed in remission after Lutetium therapy?

Some patients have remained progression-free for 5+ years. Individual outcomes vary enormously. There's no upper limit โ€” the goal is the longest meaningful disease control possible.

Will my Lu-177 ever show up on scans years later?

No. Lu-177 has a 6.7-day half-life. By 6 weeks after each cycle, radioactivity is back to baseline. There's no lingering radioactive trace years later.

Should I change anything in my life after treatment?

Most patients return to fully normal life. Some focus on lifestyle factors that may support overall health: exercise, nutrition, stress management. Discuss specifics with your team.

Have a specific question about your situation?

A free 20-minute conversation with a patient navigator can help you understand whether Lutetium therapy fits your case, what questions to ask your oncologist, and which centers might be right for you.

Navigators don't diagnose or prescribe. They help you have better conversations with the doctors who do.